Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II TrialRavindra Uppaluri, Douglas R. Adkins, Liye Zhou et al.|Clinical Cancer Research|2020Cited by 368
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancerGiacomo Oliveira, Ravindra Uppaluri, Ann Marie Egloff et al.|Science Immunology|2023Cited by 118
Enhanced pathologic tumor response with two cycles of neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV-negative head and neck squamous cell carcinoma (HNSCC).Ravindra Uppaluri, Douglas R. Adkins, Rebecca D. Chernock et al.|Journal of Clinical Oncology|2021Cited by 40
Management of Flap Failure After Head and Neck Reconstruction: A Systematic Review and Meta‐analysisAmit Walia, Patrik Pipkorn, Jake J. Lee et al.|Otolaryngology|2021Cited by 33
Risk and Rate of Occult Contralateral Nodal Disease in Surgically Treated Patients With Human Papillomavirus−Related Squamous Cell Carcinoma of the Base of the TongueAisling Last, Ryan S. Jackson|JAMA Otolaryngology–Head & Neck Surgery|2019Cited by 33